Mark C. Gillies

A Probabilistic Forecast of 12 Month Visual Outcomes of nAMD

Judy M. Simpson, Richard Walton, Vuong Nguyen, 2018 .

Macular telangiectasia type 2

Emily Y. Chew, Frank G. Holz, Tunde Peto, 2013, Progress in Retinal and Eye Research.

Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors

Aaron Y. Lee, Adnan Tufail, Vuong Nguyen, 2018, Progress in Retinal and Eye Research.

Analysis of candidate genes for macular telangiectasia type 2

Tunde Peto, Martin Friedlander, Mark C. Gillies, 2010, Molecular vision.

Diabetic Macular Edema: Current Treatments

Mark C. Gillies, M. Gillies, F. Sutter, 2007 .

Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2

Krzysztof Kiryluk, Paul S. Bernstein, Tunde Peto, 2012, PloS one.

ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder

Kathleen B. Digre, Shankaracharya, Gary L. Farley, 2019, Genetics in Medicine.